Similar articles

• [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].

  Aoyama H, Oira M, Ota T, Yoshioka S, Yoshida T. Aoyama H, et al. Nihon Eiseigaku Zasshi. 1970 Dec;25(5):468-71. Nihon Eiseigaku Zasshi. 1970. PMID: 4251106 Japanese. No abstract available.
• Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.

  Shigematsu I. Shigematsu I. Jpn J Med Sci Biol. 1975;28 Suppl:35-55. Jpn J Med Sci Biol. 1975. PMID: 136540 No abstract available.
• [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].

  Inoue N, Kuroiwa Y, Ikeda M, Yasukouchi T. Inoue N, et al. Rinsho Shinkeigaku. 1974 Oct;14(10):769-73. Rinsho Shinkeigaku. 1974. PMID: 4282713 Japanese. No abstract available.
• Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.

  Egashira Y, Matsuyama H. Egashira Y, et al. Acta Pathol Jpn. 1982;32 Suppl 1:101-16. Acta Pathol Jpn. 1982. PMID: 6316716 Review.
• [SMON--a model of the iatrogenic disease].

  Takasu T. Takasu T. Rinsho Shinkeigaku. 2003 Nov;43(11):866-9. Rinsho Shinkeigaku. 2003. PMID: 15152488 Review. Japanese.